Raúl Martín-Ruiz

Partner at Ysios Capital, Raúl graduated with a PhD degree in neurosciences. He has more than 25 years of experience in life sciences including academia, pharma and venture capital. He sits on the board of Anaconda Biomed, and previously of STAT Diagnostica (acquired by Qiagen), Prexton Therapeutics (acquired by Lundbeck) and MedLumics.